Bihter Gokce Celik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bihter Gokce Celik has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Firdevs Uluc
Department of Interdisciplinary Neuroscience, Institute of Health Sciences, Bolu Abant İzzet Baysal University, Bolu, Türkiye
3 shared publications - Hayriye Soytürk
Faculty of Agriculture, Department of Poultry Science Bolu Abant İzzet Baysal University Bolu Türkiye
3 shared publications - Sule Aydin Turkoglu
Department of Neurology, Faculty of Medicine, Bolu Abant İzzet Baysal University, Bolu, Türkiye
3 shared publications - Şeyda Karabörk
Bolu Abant İzzet Baysal University
3 shared publications - Fatma Pehlivan Karakas
Department of Biology, Faculty of Science and Art, Bolu Abant Izzet Baysal University, Bolu, Turkey
2 shared publications - Hamit Coşkun
Department of Psychology, Kocaelı Health and Technology University, Kocaelı, Turkey
2 shared publications
Latest Publications
- 30 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 212
Sexual dysfunction in multiple sclerosis: the role of orexin-A and calpain-2 — a pilot study
- 30 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 212
Sexual dysfunction in multiple sclerosis: the role of orexin-A and calpain-2 — a pilot study
- 24 August 2025
- Published by Taylor & Francis in Neurological Research
- p. 1-9
Calpain-1, not Calpain-2, has relationship with HMGB1/TLR4/NF-ΚB signalling pathway variables in multiple sclerosis
Identification of the related signalling pathways is very crucial for demyelinating diseases. The aim of this study was to investigate the relation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway in patients with Multiple Sclerosis (pwMS) and Neuromyelitis Optica Spectrum Disorder (pwNMOSD). We recruited 45 newly diagnosed patients during the relapse period, comprising 36 pwMS and 9 pwNMOSD. Twenty-eight patients with pseudotumor cerebri (pwPTC) were recruited as control. CAPN1, CAPN2, HMGB1, soluble TLR4 (sTLR4), NF-κB levels were compared between the groups by ELISA technique. pwMS had higher levels of CAPN1 than those with pwNMOSD and pwPTC. Similarly, pw MS had a considerably greater level of CAPN2 than pwPTC and pwNMOSD. Between the groups, there were no variations in HMGB1, sTLR4, NF-κB, and IL-37 levels. The CAPN1 and CAPN2 levels in the pwMS showed a favorable correlation. In pwMS, CAPN1 and HMGB1 also showed a positive correlation. This study proposes a valuable and novel perspective on the pathophysiology of MS, placing CAPN1 as a potentially important contributor to neuroinflammatory signalling via HMGB1. Future research should aim to validate these findings using larger, balanced cohorts and include longitudinal CSF and serum analysis. Experimental in vitro or in vivo studies investigating CAPN1 inhibition and its impact on HMGB1-related signalling are necessary to explore therapeutic implications.
- 24 August 2025
- Published by Taylor & Francis in Neurological Research
- p. 1-9
Calpain-1, not Calpain-2, has relationship with HMGB1/TLR4/NF-ΚB signalling pathway variables in multiple sclerosis
Identification of the related signalling pathways is very crucial for demyelinating diseases. The aim of this study was to investigate the relation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway in patients with Multiple Sclerosis (pwMS) and Neuromyelitis Optica Spectrum Disorder (pwNMOSD). We recruited 45 newly diagnosed patients during the relapse period, comprising 36 pwMS and 9 pwNMOSD. Twenty-eight patients with pseudotumor cerebri (pwPTC) were recruited as control. CAPN1, CAPN2, HMGB1, soluble TLR4 (sTLR4), NF-κB levels were compared between the groups by ELISA technique. pwMS had higher levels of CAPN1 than those with pwNMOSD and pwPTC. Similarly, pw MS had a considerably greater level of CAPN2 than pwPTC and pwNMOSD. Between the groups, there were no variations in HMGB1, sTLR4, NF-κB, and IL-37 levels. The CAPN1 and CAPN2 levels in the pwMS showed a favorable correlation. In pwMS, CAPN1 and HMGB1 also showed a positive correlation. This study proposes a valuable and novel perspective on the pathophysiology of MS, placing CAPN1 as a potentially important contributor to neuroinflammatory signalling via HMGB1. Future research should aim to validate these findings using larger, balanced cohorts and include longitudinal CSF and serum analysis. Experimental in vitro or in vivo studies investigating CAPN1 inhibition and its impact on HMGB1-related signalling are necessary to explore therapeutic implications.
- Open Access
Investigation of the Relationship Between Calpain and HMGB1/TLR4/NF-KB Signalling Pathway in Multiple Sclerosis and Other Demyelinating Diseases
Background: To develop more effective treatments for demyelinating diseases, it is essential to identify the associated signaling pathways and factors. The objective of this study was to investigate the possible correlation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway and to evaluate the influence of these proteins on Interleukin 17A (IL-17A) and Interleukin 37 (IL-37) cytokines in individuals with newly diagnosed and untreated Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD). Methods: In this pilot study, a total of 73 newly diagnosed patients were recruited, including 36 with MS, 9 with NMOSD, and an unhealthy control group composed of 28 individuals with Pseudotumour cerebri (PTC). To ensure accuracy and transparency, all groups’ demographic and clinical characteristics were meticulously described. ELISA technique was utilized to compare levels of CAPN1, CAPN2, HMGB1, TLR4, and NF-KB, as well as IL-17A and IL-37 cytokines, between the case and the unhealthy control groups. The expectation from these findings is to provide valuable insights into the pathophysiological mechanisms of these neurological disorders, possibly opening the door to novel therapeutic perspectives. Results: In patients with MS, the levels of CAPN1 were found to be higher than those in patients with NMOSD and PTC. Similarly, the level of CAPN2 was significantly higher in patients with MS than in patients with NMOSD and higher in patients with PTC than in patients with NMOSD. There were no differences in the levels of HMGB1, TLR4, NF-κB, IL-17A, and IL-37 between the groups. Age and gender did not affect any of the parameters. In the MS group, both CAPN1 and CAPN2 showed positive correlation with HMGB1, TLR4, and NF-κB levels. Conclusions: It may be suggested that CAPN1 may exhibit greater efficacy than CAPN2 during the initial stages of neuroinflammation. To obtain deeper and more guiding results of the varying levels of CAPN1 and CAPN2, and their relationship with the HMGB1/TLR4/NF-κB signaling pathway, it is advisable to conduct in-vivo and in-vitro prospective studies featuring CAPN1-specific inhibitors with larger study groups.
Open AccessInvestigation of the Relationship Between Calpain and HMGB1/TLR4/NF-KB Signalling Pathway in Multiple Sclerosis and Other Demyelinating Diseases
Background: To develop more effective treatments for demyelinating diseases, it is essential to identify the associated signaling pathways and factors. The objective of this study was to investigate the possible correlation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway and to evaluate the influence of these proteins on Interleukin 17A (IL-17A) and Interleukin 37 (IL-37) cytokines in individuals with newly diagnosed and untreated Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD). Methods: In this pilot study, a total of 73 newly diagnosed patients were recruited, including 36 with MS, 9 with NMOSD, and an unhealthy control group composed of 28 individuals with Pseudotumour cerebri (PTC). To ensure accuracy and transparency, all groups’ demographic and clinical characteristics were meticulously described. ELISA technique was utilized to compare levels of CAPN1, CAPN2, HMGB1, TLR4, and NF-KB, as well as IL-17A and IL-37 cytokines, between the case and the unhealthy control groups. The expectation from these findings is to provide valuable insights into the pathophysiological mechanisms of these neurological disorders, possibly opening the door to novel therapeutic perspectives. Results: In patients with MS, the levels of CAPN1 were found to be higher than those in patients with NMOSD and PTC. Similarly, the level of CAPN2 was significantly higher in patients with MS than in patients with NMOSD and higher in patients with PTC than in patients with NMOSD. There were no differences in the levels of HMGB1, TLR4, NF-κB, IL-17A, and IL-37 between the groups. Age and gender did not affect any of the parameters. In the MS group, both CAPN1 and CAPN2 showed positive correlation with HMGB1, TLR4, and NF-κB levels. Conclusions: It may be suggested that CAPN1 may exhibit greater efficacy than CAPN2 during the initial stages of neuroinflammation. To obtain deeper and more guiding results of the varying levels of CAPN1 and CAPN2, and their relationship with the HMGB1/TLR4/NF-κB signaling pathway, it is advisable to conduct in-vivo and in-vitro prospective studies featuring CAPN1-specific inhibitors with larger study groups.
- 29 October 2022
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (6) , 658-664
Can hyperoxic stress cause susceptibility to acute seizure in the neonatal period?: a rat study
Preterm neonates encounter hyperoxia relatively early, and are more exposed to hyperoxic stress due to their insufficient antioxidant defense mechanisms. This study was planned around the hypothesi...
- 29 October 2022
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (6) , 658-664
Can hyperoxic stress cause susceptibility to acute seizure in the neonatal period?: a rat study
Preterm neonates encounter hyperoxia relatively early, and are more exposed to hyperoxic stress due to their insufficient antioxidant defense mechanisms. This study was planned around the hypothesi...
- 18 October 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (3) , 606-613
Evaluation of the Protective Effect of The Cup Therapy on the Epileptic Seizure in Rats
Objective: Cup therapy has an important place in traditional and complementary medicine applications. The purpose of our study, this is the first time to investigate the protective effect of cup therapy in rats on experimentally generated epileptic seizures in new rat modeling created by different anatomic regions. Methods: In our study, 42 Wistar albino rats 3-4 months old (200-250 g) were used. Four other groups (n=7) except G3 and G4, 24 hours after cup therapy application, PTZ (35 mg/kg, sc., 0.2 cc) was injected, followed by behavioral epilepsy scoring. Results: In the 'Open Area' and 'Elevated Plus Maze' tests, there was no behavioral difference between the cup therapy group and the control group (p > 0.05). Given all the parameters, the G4 group significantly reduces the seizure compared to other groups (p < 0.05). There is a significant difference in G2, G5 and G6 groups compared to G3 in the phases parameter (p < 0.05). Conclusions: In this study, the new wet cup therapy (G2), which was applied for the first time, had a protective effect on seizures. G2, G5 and G6 groups are observed to suppress seizures compared to G3. Our findings are expected to contribute greatly to animal model analysis in the future.
- 18 October 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (3) , 606-613
Evaluation of the Protective Effect of The Cup Therapy on the Epileptic Seizure in Rats
Objective: Cup therapy has an important place in traditional and complementary medicine applications. The purpose of our study, this is the first time to investigate the protective effect of cup therapy in rats on experimentally generated epileptic seizures in new rat modeling created by different anatomic regions. Methods: In our study, 42 Wistar albino rats 3-4 months old (200-250 g) were used. Four other groups (n=7) except G3 and G4, 24 hours after cup therapy application, PTZ (35 mg/kg, sc., 0.2 cc) was injected, followed by behavioral epilepsy scoring. Results: In the 'Open Area' and 'Elevated Plus Maze' tests, there was no behavioral difference between the cup therapy group and the control group (p > 0.05). Given all the parameters, the G4 group significantly reduces the seizure compared to other groups (p < 0.05). There is a significant difference in G2, G5 and G6 groups compared to G3 in the phases parameter (p < 0.05). Conclusions: In this study, the new wet cup therapy (G2), which was applied for the first time, had a protective effect on seizures. G2, G5 and G6 groups are observed to suppress seizures compared to G3. Our findings are expected to contribute greatly to animal model analysis in the future.
- 23 April 2021
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 38 (3) , 331-335
The effect of intra-amygdalar leptin administration on anxiety, depression and learning behaviors in rats
Leptin is released by adipose tissue. Leptin can cross the blood–brain barrier and bind to receptors on neurons in brain areas to exert its biological function when released into circulation. This study aimed to determine the influences of intra-amygdalar administration of high and low doses of leptin on anxiety, depression, learning behaviors of rats. In the experimental protocol I, intra-amygdalar injection of high and low doses of leptin (0.1 and 1 μg/ kg) and saline were administered 30 min before the behavioral tests. Then, the animals were exposed to open field, elevated plus maze, Porsolt and Morris water maze tests for measuring of behaviors. In experimental protocol 2, the cerebrospinal fluids of all groups of experimental protocol 1 were collected by microdialysis method and then were analyzed by HPLC. The effect of the low dose of leptin was significant on the open field. The effect of the high and low dose of leptin was significant on the elevated plus maze test. The effect of the low dose of leptin was significant on mobility in the center of the Porsolt. A high dose of leptin group had spent less time around the platform than controls in the Morris water maze test. HPLC analysis showed that the amount of serotonin and glutamate in the amygdala region increased after low dose leptin administration. Intra-amygdalar injection of low doses of leptin may decrease anxiety and depression-like behavior in rats by increasing serotonin and glutamate levels in the amygdala.
- 23 April 2021
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 38 (3) , 331-335
The effect of intra-amygdalar leptin administration on anxiety, depression and learning behaviors in rats
Leptin is released by adipose tissue. Leptin can cross the blood–brain barrier and bind to receptors on neurons in brain areas to exert its biological function when released into circulation. This study aimed to determine the influences of intra-amygdalar administration of high and low doses of leptin on anxiety, depression, learning behaviors of rats. In the experimental protocol I, intra-amygdalar injection of high and low doses of leptin (0.1 and 1 μg/ kg) and saline were administered 30 min before the behavioral tests. Then, the animals were exposed to open field, elevated plus maze, Porsolt and Morris water maze tests for measuring of behaviors. In experimental protocol 2, the cerebrospinal fluids of all groups of experimental protocol 1 were collected by microdialysis method and then were analyzed by HPLC. The effect of the low dose of leptin was significant on the open field. The effect of the high and low dose of leptin was significant on the elevated plus maze test. The effect of the low dose of leptin was significant on mobility in the center of the Porsolt. A high dose of leptin group had spent less time around the platform than controls in the Morris water maze test. HPLC analysis showed that the amount of serotonin and glutamate in the amygdala region increased after low dose leptin administration. Intra-amygdalar injection of low doses of leptin may decrease anxiety and depression-like behavior in rats by increasing serotonin and glutamate levels in the amygdala.
- Open Access
- 13 October 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF BIOLOGY
- Vol. 44 (5) , 238-251
Anxiolytic, antioxidant, and neuroprotective effects of goji berry polysaccharides in ovariectomized rats: experimental evidence from behavioral, biochemical, and immunohistochemical analyses
Recent studies have indicated that polysaccharides, the main component of the Lycium barbarum L. fruit, have beneficial effects (e.g., anxiolytic, antioxidant, and neuroprotective) on humans and rodents. However, the effects of different dosages of such polysaccharides on ovariectomized rats and their underlying mechanisms in the brain have not been evaluated in the literature. Here, we aimed to evaluate the effects of the high and low doses of polysaccharides obtained from Lycium barbarum fruits (HD-LBP and LD-LBP, respectively) on anxious behaviors via behavioral (using the OFT and EPM), biochemical (using ELISA), and immunohistochemical (using immunohistochemical staining) measures in detail. Two weeks after ovariectomy, the rats were randomly assigned to either the treatment conditions [control (DW, 3 mL/kg, p.o., per day), LD-LBP (20 mg/kg, 3 mL/kg, p.o., per day), HD-LBP (200 mg/kg, 3 mL/kg, p.o., per day), 17 β-ES (1 mg/kg, 3 mL/kg, p.o., per day), DZ(1 mg/kg, 3 mL/kg, p.o., per day)] or operation type [SHAM (pseudo-ovariectomized) and OVX (ovariectomized)]. The treatments were applied for 30 consecutive days, and then serum and brain tissue samples of all rats were collected. Biochemical (SOD, CAT, GPX, MDA, and 17 β-ES) and immunohistochemical (BDNF, SER, and apoptosis) analyses of the samples were performed as well. The rats administered HD-LBP and LD-LBP were less anxious than the control groups. The HD-LBP–treated rats had high levels of SOD and low levels of MDA in their serum samples. Moreover, HD-LBP and drug-treated groups had a high number of SER receptors and BDNF-positive cells and a low number of TUNEL-positive cells in their hippocampal brain tissues. The HD-LBP treatments decrease anxious behavior by increasing antioxidant enzyme activities, hippocampal SER and BDNF neurotransmitter levels and decreasing the TUNEL-positive cell count of ovariectomized rats. Given these findings, we suggest that menopause-induced symptoms of anxiety can be reduced by polysaccharides obtained from goji berry fruits, and that these findings will be beneficial for the production studies of natural herbal-origin antianxiety (anxiolytic) drugs in the future.
- 13 October 2020
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF BIOLOGY
- Vol. 44 (5) , 238-251
Open AccessAnxiolytic, antioxidant, and neuroprotective effects of goji berry polysaccharides in ovariectomized rats: experimental evidence from behavioral, biochemical, and immunohistochemical analyses
Recent studies have indicated that polysaccharides, the main component of the Lycium barbarum L. fruit, have beneficial effects (e.g., anxiolytic, antioxidant, and neuroprotective) on humans and rodents. However, the effects of different dosages of such polysaccharides on ovariectomized rats and their underlying mechanisms in the brain have not been evaluated in the literature. Here, we aimed to evaluate the effects of the high and low doses of polysaccharides obtained from Lycium barbarum fruits (HD-LBP and LD-LBP, respectively) on anxious behaviors via behavioral (using the OFT and EPM), biochemical (using ELISA), and immunohistochemical (using immunohistochemical staining) measures in detail. Two weeks after ovariectomy, the rats were randomly assigned to either the treatment conditions [control (DW, 3 mL/kg, p.o., per day), LD-LBP (20 mg/kg, 3 mL/kg, p.o., per day), HD-LBP (200 mg/kg, 3 mL/kg, p.o., per day), 17 β-ES (1 mg/kg, 3 mL/kg, p.o., per day), DZ(1 mg/kg, 3 mL/kg, p.o., per day)] or operation type [SHAM (pseudo-ovariectomized) and OVX (ovariectomized)]. The treatments were applied for 30 consecutive days, and then serum and brain tissue samples of all rats were collected. Biochemical (SOD, CAT, GPX, MDA, and 17 β-ES) and immunohistochemical (BDNF, SER, and apoptosis) analyses of the samples were performed as well. The rats administered HD-LBP and LD-LBP were less anxious than the control groups. The HD-LBP–treated rats had high levels of SOD and low levels of MDA in their serum samples. Moreover, HD-LBP and drug-treated groups had a high number of SER receptors and BDNF-positive cells and a low number of TUNEL-positive cells in their hippocampal brain tissues. The HD-LBP treatments decrease anxious behavior by increasing antioxidant enzyme activities, hippocampal SER and BDNF neurotransmitter levels and decreasing the TUNEL-positive cell count of ovariectomized rats. Given these findings, we suggest that menopause-induced symptoms of anxiety can be reduced by polysaccharides obtained from goji berry fruits, and that these findings will be beneficial for the production studies of natural herbal-origin antianxiety (anxiolytic) drugs in the future.